New Treatment for Childhood Arthritis

Friday, 10 May 2013 11:47 AM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
Novartis said the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serious form of childhood arthritis.

Ilaris inhibits interleukin-1 beta, excessive production of which plays a prominent role in certain inflammatory diseases, the company said.

The drug is the only approved treatment specifically for the condition that can be given as a monthly subcutaneous injection, Novartis said.

Ilaris is also approved in the European Union for the treatment of refractory gouty arthritis, Novartis said.

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Alzheimer's Combo Treatment

Wednesday, 24 Dec 2014 10:15 AM

The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Ac . . .

Immune Drug Fights Skin Cancer

Monday, 22 Dec 2014 16:07 PM

TheU.S. Food and Drug Administration approved Bristol-Myers Squibb's skin cancer drug, more than three months before the . . .

First New Flu Treatment in 15 Years

Monday, 22 Dec 2014 08:19 AM

The U.S. Food and Drug Administration approved Biocryst Pharmaceuticals' intravenous flu drug, sending the company's sha . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved